Author:
Rooney Mary R.,Wang Dan,McEvoy J. William,Juraschek Stephen P.,Chalmers John,Woodward Mark,Selvin Elizabeth
Funder
NIDDK
National Institutes of Health
NHLBI
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference19 articles.
1. Glycaemic variability in diabetes: clinical and therapeutic implications;Ceriello;Lancet Diabetes Endocrinol,2019
2. Glycemic variability and cardiovascular disease in patients with type 2 diabetes;Martinez;BMJ Open Diabetes Res Care,2021
3. Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial;Selvin;Diabetes Obes Metab,2019
4. Association of 1,5-anhydroglucitol with cardiovascular disease and mortality;Selvin;Diabetes,2016
5. Association of a biomarker of glucose peaks, 1,5-anhydroglucitol, with subclinical cardiovascular disease;Liang;Diabetes Care,2016